Podcasts about commercialisation

Dr Anne Lane, chief executive officer of UCL Ventures, discusses why commercialising research at British universities remains a challenge despite significant will and the enormous impact of spending money on cutting-edge research.  UCL Ventures, formerly UCL Business, is the commercialisation arm of one of the world's most prestigious universities. 

If your MedTech product isn't selling as quickly as expected, are more salespeople really going to fix the problem?When a MedTech launch underperforms, hiring more salespeople, recruiting another distributor or attending more exhibitions can feel like the obvious answer. But if the market hasn't been prepared and customers don't yet see a compelling reason to change, more sales activity won't solve the underlying problem. In this episode, Hakeem explains why successful MedTech commercialisation and export starts long before launch—and why understanding and preparing your market can save you from trying to force adoption later.In this episode you'll discover:Why MedTech commercialisation should begin months before your product launches, rather than after regulatory approval.Why adding salespeople or export distributors won't fix a market that isn't ready to adopt your product.How understanding what keeps your customers awake at night can help you create demand, prepare the market and accelerate adoption.ActionListen now to learn how to prepare your market before you commercialise or export your MedTech product, so your sales team can convert demand rather than having to create it from scratch.Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Can you make espresso with room-temperature water and sound waves? Dr Francisco Trujillo and his team at UNSW have developed an entirely new brewing process that uses ultrasound to produce espresso-strength coffee in under three minutes, while using around one-quarter of the energy of a traditional espresso machine. In this episode, Francisco takes us inside the science of ultrasonic coffee. We unpack acoustic cavitation, the microscopic bubbles that pit and fracture coffee grounds, why tamping matters far less in this system, and how the team built the technology into something that still looks surprisingly close to a normal espresso machine. We also get into the taste test. One hundred regular coffee drinkers compared the ultrasonic brew with traditional espresso, with no significant difference found across the key sensory measures. Francisco explains where the drinks do differ, including crema, bitterness and aftertaste, and why the biggest opportunity may not be your local café at all, but large-scale ready-to-drink coffee production. If you're new here (welcome), our show dives into some of the best coffee conversations on the internet, but we will always remind ourselves at the end of the day: It's Just Coffee! CHAPTERS! 00:00 A New Way to Brew Coffee 01:17 How Ultrasonic Espresso Works 02:18 Where the Idea Came From 03:29 From Three-Minute Cold Brew to Espresso Strength 04:58 Acoustic Cavitation Explained 10:35 Brew Ratio, Grind Size and Tamping 13:54 Is It Really Espresso? 16:34 Why the Brew Takes Three Minutes 18:04 Testing Different Coffees and Roast Levels 19:29 Brewing With Room-Temperature Water 21:40 The Blind Taste Test 28:24 What Happens to Aroma? 31:05 Extraction Yield and TDS 32:23 Less Bitterness and a Cleaner Aftertaste 33:48 The Energy-Saving Opportunity 35:41 APAX LAB 36:54 Can Ultrasonic Coffee Scale Up? 39:19 Patents and Commercialisation 42:04 Francisco's First Coffee Project 44:39 The Team Behind the Research 45:08 Where to Find Francisco's Work Dr Francisco Trujillo, UNSW: https://www.unsw.edu.au/staff/francisco-trujillo Ultrasonic espresso research: https://doi.org/10.1016/j.jfoodeng.2026.113193 Want more coffee content? IT'S JUST COFFEE: https://linktr.ee/itsjustcoffeepod Want to get in touch? Hit us up at hello@itsjustcoffeepod.com with your questions, hot takes or guest suggestions. Proudly sponsored by: APAX LAB: https://apaxlab.com/ Riverina Fresh: https://www.riverinafresh.com.au/ Thanks for listening! Learn more about your ad choices. Visit megaphone.fm/adchoices

Are you pricing your MedTech product based on evidence and value... or simply making an educated guess?Pricing is one of the most important commercial decisions you'll make, yet many MedTech founders spend years developing their product and only a few hours deciding what it's should cost. In this episode, Hakeem shares a practical five-step framework to help you understand your market, quantify your value, validate your pricing, and develop a pricing strategy that supports successful commercialisation and export.In this episode, you'll discover:Why competitor pricing should inform your thinking, but never determine your pricing strategy.How to assess the value your MedTech product creates and use it to justify your price.A practical framework for validating your pricing with clinicians, procurement teams, distributors, and customers before commercialisation and export.Listen now to learn how to price your MedTech product with confidence, strengthen your commercialisation strategy, and avoid costly pricing mistakes before entering new markets.If you need help with your pricing, message me on linkedin with the words "pricing supportThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

As you know, we're big fans of science here on Afternoons so over the next few weeks Jesse will be speaking to some of the finalists of the KiwiNet research Commercialisation awards. The awards celebrate companies making the leap from science research to science commerce Today Jesse spoke to Mick Riley from Forever Harvest, a company growing fruits and nuts - but get this - without the tree. [picture id="4KHGIPV_Mick_Riley_PFR0548_Edit_jpg" crop="16x10" layout="full"]

Clement Manyathela speaks to Tom Crotty, the Head of Tech Marketing and Commercialisation at Liberty about the importance of planning for your future. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Is your MedTech product genuinely ready for commercialisation and export, or are you simply working through a checklist?Many MedTech founders believe that regulatory approval, clinical evidence, patents, and distributor interest mean they're ready for commercial success. But commercial readiness is about far more than ticking boxes. In this episode, Hakeem explains why successful commercialisation depends on multiple factors working together and introduces a structured way of assessing whether your MedTech product is truly ready for commercialisation and export before investing significant time and money.In this episode, you'll discover:Why regulatory approval, clinical evidence, and distributor interest don't automatically mean your MedTech product is commercially ready.The key questions that reveal whether your product is ready for commercialisation, adoption, and export.How to identify commercial risks early so you can make better investment, launch, and export decisions with greater confidence.Listen now to learn how to assess your MedTech product's commercial readiness, strengthen your commercialisation strategy, and export with greater confidence.Message me with CPI on Linkedin, to really see if your product is ready for commercialisationThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

This business spotlight explores how RLF AgTech is turning decades of agricultural research into practical products that help farmers improve productivity and profitability.Chairman Ben Barlow shares his journey from building and exiting New Edge Microbials to leading RLF AgTech, explaining why commercialisation is often the missing link between great science and widespread adoption. He discusses what attracted him to the business, how RLF has built on more than 20 years of research and field trials, and why the future of Australian agriculture depends on making innovation practical at the farm gate.This episode explains how RLF AgTech's approach to plant nutrition, biologicals and local manufacturing is helping strengthen farm businesses while positioning Australian innovation for global growth. For anyone interested in ag tech, agricultural productivity or the future of farming, this is a practical and insightful conversation.RLF AgTech is an Australian agricultural technology company developing plant nutrition and biological solutions that improve crop performance. The business combines decades of research, extensive field trials and local manufacturing to deliver products that integrate into existing farming systems while supporting more productive and resilient agriculture.Key insights from the conversation:How RLF AgTech is commercialising decades of agricultural researchWhy adoption depends on trust, education and on-farm resultsThe role of local manufacturing in strengthening Australian agricultureWhy improving farm profitability is the foundation for future ag tech adoptionBen's outlook on the future of Australian agriculture and agricultural innovationChapters:00:00 Introduction and Ben Barlow's background01:34 Ben's journey since last conversation02:30 Focus on plant, animal, and soil health03:57 Deep science and commercial potential of biologicals05:55 Involvement with RLF AgTech07:52 Opportunities in biologicals and crop yields10:54 Australian agriculture's adoption challenges14:13 Market opportunities and niche products17:06 Global markets and export potential20:02 Local manufacturing and supply chain resilience23:11 Future of agritech and investment challenges26:08 Leadership, risk, and strategic growth30:00 Opportunities and pathways for Australian agriculture32:50 Skills for the next generation of farmers33:56 Closing remarks and key takeaways

The Bundle with Yannick Ramcke of OneFootball and Murray Barnett of West26 Sport. Agenda:1. The Commercialisation of the Hydration Break2. Did the Ratings Success Change US Football Broadcasting?3. Sky's £1.6bn ITV Takeover: The Return of the Full-Funnel Broadcaster4. Is the Sports Doc Gold Rush Over?5. DAZN's A$5.3bn NRL Bet Cross-cutting threadsReach vs revenueCommercial innovation is a ratchetEveryone's paying not to loseThe access era is endingThe Unofficial Partner Scholarship - Applications Now Open for the Institute of Sports Humanities (ISH)

What if the success of your MedTech product was determined months before launch?Many MedTech founders believe that strong clinical evidence and a great product are enough to drive adoption. In reality, successful launches begin long before launch day. In this episode, Hakeem shares the five biggest lessons from his conversation with Holly Miller, revealing how to prepare the market, build demand, and move your product from a "nice-to-have" to a "must-have."Listeners will discover:Why clinical evidence alone doesn't create adoptionHow to position your MedTech product as a must-have for the right audienceThe five practical lessons that help founders build demand before launch and improve their chances of commercial successPlay this episode now to discover the five lessons that will help you prepare the market, accelerate adoption, and give your MedTech product the strongest possible commercial launch.Full episode with Holley - #211Book a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians and solo founders feeling stuck in turning their medical devices into real businesses, with practical insight on go to market strategy, sales strategy, product launch, sales plans, business growth, exporting, selling internationally and how to scale up their international sales in MedTech.

Canada produces world-leading science, engineering, and AI research. So why does so much of that research still commercialize outside of Canada?In this episode of TechSurge, host Nic Brathwaite puts that question to four leaders at two of Canada's top research universities: Mary Wells (Dean of Engineering) and Chris Houser (Dean of Science) at the University of Waterloo, and Heather Sheardown (Dean of Engineering) and Gianni Parise (VP Research) at McMaster.At Waterloo, Mary Wells traces how the university's origin produced one of the world's most influential co-op programs and a creator-owned IP policy that lets inventors keep their ideas, making the school a talent engine for global tech. The group digs into Canada's AI paradox, foundational research and talent but far less of the economic value, and what quantum, robotics, and advanced manufacturing show about getting research to market.McMaster runs a different model, built on health sciences, nuclear research, and problem-based learning. Heather Sheardown explains the McMaster Method and why it matters in an AI-shaped future. Gianni Parise argues for commercialization as a core university function, with work spanning AI-assisted drug discovery, inhaled vaccines, critical-mineral-free motors, and a campus nuclear reactor that supplies much of the world's iodine-125 for prostate cancer treatment. They also unpack Fusion Pharmaceuticals, the McMaster spin-out acquired by AstraZeneca, and what it reveals about university commercialization.Together, these conversations ask what universities must become in an era defined by AI, deep tech, national competitiveness, and the urgent need to move ideas from the lab into the world.Sign up for our newsletter at techsurgepodcast.com for updates on upcoming TechSurge Live Summits and future episodes.Speaker Profiles and LinksMary Wells - University of Waterloo Profile: https://uwaterloo.ca/engineering/about/dean-engineerinChris Houser - University of Waterloo profile: https://uwaterloo.ca/earth-environmental-sciences/profile/chouserHeather Sheardown - McMaster Engineering profile: https://www.eng.mcmaster.ca/chemeng/faculty/dr-heather-sheardown/Gianni Parise - McMaster Experts Profile: https://experts.mcmaster.ca/people/parisegChapters: 0:00 Highlights0:56 Welcome 2:39 Waterloo's origin story 4:51 Creator-owned IP and the Waterloo model 7:42 The Co-op Flywheel 8:56 Canada's AI paradox: world-class research, slower domestic value capture 10:21 AI, Regulation, Trust, and Canadian Competitiveness 17:09 Rethinking the PhD for Commercialisation 21:43 Inside Waterloo's labs 30:14 What Waterloo wants to be in ten years: builders of the country 32:39 Meet McMaster: health sciences, nuclear capability, and research intensity 34:12 The McMaster Method 35:11 Research, Health, and Commercialisation 40:45 McMaster Labs: Heat, Motors and Health Innovation 47:13 Bioinnovation, Nuclear Research and Fusion Pharmaceuticals 58:43 The university of 2035: less lecture, deeper societal impact References Mentioned and Further ReadingUniversity of Waterloo Policy 73 - Intellectual Property Rights: https://uwaterloo.ca/secretariat/policies-procedures-guidelines/policies/policy-73-intellectual-property-rightsUniversity of Waterloo - Our IP policy: https://uwaterloo.ca/entrepreneurship/our-ip-policyUniversity of Waterloo Co-op programs: https://uwaterloo.ca/future-students/co-opUniversity of Waterloo - Academy of Research Commercialization: https://uwaterloo.ca/conrad-school-entrepreneurship-business/graduate-students/academy-research-commercialization-arcOpen Quantum Design: https://openquantumdesign.org/Institute for Quantum Computing, University of Waterloo: https://uwaterloo.ca/institute-for-quantum-computing/CIFAR - Pan-Canadian Artificial Intelligence Strategy: https://cifar.ca/ai/Government of Canada / ISED - Pan-Canadian Artificial Intelligence Strategy: https://ised-isde.canada.ca/site/ised/en/pan-canadian-artificial-intelligence-strategyStatistics Canada - Understanding Canada's innovation paradox: https://www150.statcan.gc.ca/n1/pub/36-28-0001/2024007/article/00002-eng.htmCouncil of Canadian Academies - Innovation and Business Strategy: Why Canada Falls Short: https://cca-reports.ca/wp-content/uploads/2018/10/2009-06-11-innovation-report-1.pdfKPMG / University of Melbourne - Trust, attitudes and use of artificial intelligence: https://assets.kpmg.com/content/dam/kpmg/ca/pdf/2025/07/trust-in-ai-en-report.pdfMcMaster - Our approach to teaching and learning / Problem-Based Learning: https://provost.mcmaster.ca/teaching-learning/our-approach/McMaster - Evidence-based medicine: https://fhshrwelcome.mcmaster.ca/did_you_know/evidence-based-medicine/McMaster Nuclear Reactor - Medical Isotopes: https://nuclear.mcmaster.ca/medical-isotopes/McMaster Industry Liaison Office - IP and commercialization FAQ: https://research.mcmaster.ca/mcmaster-industry-liaison-office-milo/ip-education/intellectual-property-guides/faqs/McMaster - AstraZeneca to acquire McMaster-supported Fusion Pharmaceuticals: https://news.mcmaster.ca/astrazeneca-to-acquire-mcmaster-supported-fusion-pharmaceuticals/Fusion Pharmaceuticals - FACIT investment and CPDC spin-out background: https://fusionpharma.com/facit-announces-investment-in-fusion-pharmaceuticals-and-alpha-emitting-radiotherapeutics/PubMed - Evidence-based medicine and problem-based learning at McMaster: https://pubmed.ncbi.nlm.nih.gov/31617018/ScienceDirect - Fifty Years on: The first problem-based learning programme at McMaster:

What occurs when an athlete faces the decision to turn professional? Is professionalism a career, a mindset, a drive to win, discipline, or something different? Patrick discusses this with Cecily Schmidt, a D1 athlete, basketball player, and VP of Footwear Product Creation and Commercialisation at Koobz.

John Maytham speak to Professor Anusuya Chinsamy-Turan, Palaeobiologist in the Department of Biological Sciences at the University of Cape Town, about the T- Rex fossil that could possibly become the most expensive fossil ever – many scientist do not agree. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

An international review of policy changes over the last 25 years urges caution about allowing cannabis to be sold commercially. 

In this upbeat interview, CEO James Hickman and CFO Andrew Richards of Finseta – a specialist B2B payments and foreign exchange platform - take me through last week's positive FY'25 results and ‘in line' outlook.00:00 Business growth drivers and Finseta's key USPs05:00 Financial highlights & 54% expansion in corporate sales to £7.1m (57% of group)08:40 Commercialisation and new product strategies13:30 FY'26 outlook, valuation & closing remarks

Aujourd'hui dans le "Décryptage", David Barroux analyse les récentes annonces du groupe automobile européen Stellantis. Celui-ci a en effet décidé de s'associer avec le constructeur chinois Leapmotor, en prenant une participation dans son capital et en créant une coentreprise. Cette alliance permettra à Stellantis, qui contrôle des marques comme Peugeot et Fiat, de produire et de commercialiser des modèles chinois en Europe, tout en donnant à Leapmotor un accès au marché européen. Une stratégie pragmatique face aux défis de l'industrie automobile, marquée par des surcapacités et une concurrence accrue des constructeurs asiatiques.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

200 episodes in, and The NN Pod marks its double century by stepping beyond Arsenal's immediate pressures to survey a chaotic football landscape.From Matchweek 34's relegation drama and Nottingham Forest's survival fight, to Sunderland's collapse, Spurs and West Ham's late escapes, and a promotion race delivering football at its most dramatic, the wider game provided no shortage of volatility.The show's VARse segment once again dissects the latest refereeing controversies — from disputed disallowed goals and goalkeeper collisions to penalty farces and the ongoing inconsistencies surrounding Howard Webb's PGMOL.Elsewhere, the pod explores the growing tension around football's commercial future: Wrexham's meteoric rise, lower-league authenticity, and what financial disruption means for the integrity of the pyramid.Chelsea's latest managerial collapse under “LinkedIn Liam” also comes under the microscope, as deeper structural dysfunction at Stamford Bridge raises fresh questions about ownership, recruitment, and long-term direction.There's also reflection on Manchester United's unexpected resurgence, promotion races across the divisions, and the evolving shape of European qualification battles.A landmark episode covering football's instability, absurdity, and enduring drama — all through The NN Pod lens.Chapters:(00:00) - Arteta's Non-Negotiables & Intro(00:18) - Week in Football Show Intro & Episode 200 Milestone(01:32) - Arsenal 200th Appearance Quiz & Double Century Discussion(03:57) - Whip Around the Grounds: Matchweek 34 Relegation Battle & Premier League Roundup(04:55) - VARse: Sunderland vs Nottingham Forest Disallowed Goal Debate(09:30) - VARse: West Ham vs Everton Penalty Controversies(17:17) - VARse: Liverpool vs Crystal Palace Injury & Goal Debate(20:30) - Relegation Race Analysis: Forest, Spurs, West Ham & Leeds(24:50) - Champions League Qualification Race & European Places Battle(29:04) - The Week That Was: Rochdale vs York Promotion Drama(32:04) - Championship, League One & League Two Promotion/Relegation Battles(34:36) - Millwall, Football Culture & Premier League Return Debate(44:10) - Wrexham's Rise, Commercialisation & Football Integrity(50:11) - Chelsea Turmoil: Liam Rosenior Exit & Ownership Dysfunction(58:42) - Outro & Atletico Review Preview

TU Dublin Innovation has announced a major surge in commercially focused research activity valued at approximately €3 million, securing five Enterprise Ireland Commercialisation Fund (CF) awards in 2025, significantly exceeding its annual target of three. The achievement marks a dramatic increase from 2024, when TU Dublin secured just one CF award, and signals a strong return to the university's baseline performance over the past two years. This milestone reflects a substantial investment of time, expertise and collaboration across TU Dublin's Innovation Office, case managers and research community. It also positions the university strongly for further growth in 2026, with a healthy pipeline already underway. One Proof of Concept (PoC) application has already been submitted, a second is in development, and additional opportunities are actively being explored. The five Enterprise Ireland awards include two full Commercialisation Fund projects and three Proof of Concept awards. As seen in 2024, both full CF projects secured significant funding, reinforcing TU Dublin's focus on high-value, high-impact research with strong commercial potential. The SIMIR project, awarded €721,533 and led by Dr Brian Vaughan at TU Dublin in collaboration with the Royal College of Surgeons in Ireland, is developing an immersive digital simulation platform designed to prepare medical trainees for real clinical environments. The platform combines clinical decision-making with essential soft skills, including communication, teamwork and situational awareness. Led by Dr Steven Davy at TU Dublin, the LiteStream project, awarded €653,472, is creating a next-generation telemedicine solution that uses AI-driven visual analysis and advanced video compression to help clinicians identify key patient cues during remote consultations, even in low-bandwidth environments. Anastasia Negru, Commercialisation Lead, LiteStream, commented that: 'We're tackling a €432 billion market with technology that solves three critical problems: doctors missing visual cues in remote consultations, bandwidth barriers in rural areas, and overwhelming documentation burden. The Enterprise Ireland Commercialisation Fund gives us the resources to conduct trials with clinical partners across Ireland, Sweden, Spain, the US and beyond and prove that Irish innovation can lead the global healthcare AI revolution.' In addition to its Enterprise Ireland success, TU Dublin has also secured four ARC Hub for ICT Proof of Concept awards, bringing the total number of new commercialisation-focused projects funded in 2025 to nine. Dr Paul Maguire, Head of Innovation and Knowledge Transfer at TU Dublin, commented: 'These awards mark a pivotal moment for TU Dublin Innovation, reflecting the determination and expertise of our researchers and innovation office team. We are building momentum at a remarkable pace, and the strength of our 2026 pipeline shows that this is only the beginning. Our university is firmly positioning itself as a leader in translating high impact research into real world commercial and societal value.' These achievements underline TU Dublin's growing reputation as a leader in research translation, innovation and industry engagement, with a clear focus on turning breakthrough ideas into real-world solutions that deliver commercial and societal impact. TU Dublin Innovation is co-funded by the Government of Ireland and the European Union through the ERDF Southern, Eastern & Midland Regional Programme 2021-27. See more stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help pro...

With oil costing more than US$100 a barrel, there's never been a better time to go green. Meet some of the movers and shakers who are funding and fast-tracking clean energy solutions. In this episode, hosts David and Celeste are joined by David McFarlane and Desire Runganga from the GreenTech Hub – a venture that's helping to solve global sustainability challenges through novel thinking, commercialisation and tech development.  Australia's progress on the Paris Agreement [01:07] The critical minerals paradox [03:55] Economic disconnect in energy transition [09:22] Bargaining problems in mineral supply [12:19] GreenTech Hub innovations [16:08] Business imperatives for going green [20:42] Economic viability of clean energy [24:13] Generational change [36:16] Learn more GreenTech Hub Connect with our guests Jason McFarlane Jason is the inaugural Director of the Western Australian GreenTech Hub. He's an economic strategist with a strong understanding of green technology trends and the practical realities of commercialisation.  Desire Runganga Desire is an engineer with postgraduate degrees in mining, economics, and law. He's currently completing his PhD at the Curtin Institute for Energy Transition, focusing on global collaboration in securing critical minerals.  Join Curtin University This podcast is brought to you by Curtin University. Curtin is a global university known for its commitment to making positive change happen through high-impact research, strong industry partnerships and practical teaching. Work with us Study a research degree Start postgraduate education Interested in energy? Explore these courses: Master of Science (Minerals and Energy Economics) Master of Environment and Climate Emergency Got any questions or suggestions? Email thefutureof@curtin.edu.au Transcript Read the transcript: https://thefutureof.simplecast.com/episodes/energy/transcript Behind the scenes Hosts: David Karsten and Celeste Fourie Writer: Zoe Taylor Producer: Emilia Jolakoska Executive Producer: Natasha Weeks First Nations Acknowledgement Curtin University acknowledges Aboriginal and Torres Strait Islander people, the First Peoples of this place we call Australia, and the First Nations peoples connected with our global campuses. We are committed to working in partnership with Custodians and Owners to strengthen and embed First Nations' voices and perspectives in our decision-making, now and into the future. Curtin University supports academic freedom of speech. The views expressed in The Future Of podcast may not reflect those of Curtin University.

Autrefois assignés à des tâches répétitives en milieu industriel, les robots deviennent capables, grâce aux avancées en intelligence artificielle de percevoir, d'adapter leurs gestes et d'interagir avec leur environnement. Déjà présente dans de nombreux secteurs industriels, la robotique entre dans une nouvelle phase grâce à l'IA, avec des perspectives concrètes pour l'industrie, la santé et l'assistance aux personnes. Ces progrès ouvrent des perspectives pour sécuriser des interventions dangereuses pour les humains ou automatiser certaines opérations exigeantes. Pour autant, même des gestes qui nous semblent élémentaires - comme saisir un verre - demeurent des défis techniques majeurs, révélant l'écart entre l'apparente simplicité de nos actions et la réalité de l'ingénierie robotique.Dans cet épisode d'Écoutons le Futur, nos invités analysent cette évolution : de l'histoire de la robotique industrielle à l'émergence de nouvelles capacités techniques, des différences culturelles dans la perception des machines, jusqu'aux enjeux concrets de déploiement dans l'industrie. Ils abordent également les questions de responsabilité juridique, les défis de cybersécurité et de gouvernance des données ainsi que l'importance du cadre éthique qu'il reste à structurer pour une adoption maîtrisée de ces systèmesPrésents sur notre plateau :- Philippe Dewost, Président chez Phileos- Olivier Parent, Directeur des études chez Comptoir Prospectiviste- Nizar Ouarti, Chef de l'équipe Asimov du laboratoire ISIR ​- Alexandre Embry, Directeur associé chez Capgemini ​ en charge de l'AI Robotics & Experiences Lab​ chez CapgeminiUne émission animée par Valère Corréard

Tom Chi is the Founding Partner of At One Ventures, an early-stage venture capital firm that supports companies and backs founders working in areas such as climate technology, energy, manufacturing, and infrastructure, with the aim of helping the global economy move towards a regenerative and sustainable model. Tom Chi is also an author and thought leader in the field of climate and sustainability. His book Climate Capital: Investing in the Tools for a Regenerative Future explores how investment can support technologies that enable economic growth while restoring natural systems. Read more about Tom Chi: https://businessabc.net/wiki/tom-chiTom Chi Interview Questions00:00 - Intro04:08 - Background09:10 Career Highlights12:09 - Google Glasses15:00 Deep Tech Products & UI/UX22:05 Rapid Prototyping32:41 - Commercialisation of Products40:09 At One Ventures43:52 Climate Tech & Innovation49:20 - Climate Capital58:19 - Ecological & Economic Resilience01:05:56 - Mitigating AI disruptions01:18:40 - Managing disruptions01:26:21 - Hope for the future01:32:50 - ClosureUseful Links and Resourceshttps://citiesabc.com/rethinking-climate-capital-why-the-economy-is-a-subset-of-ecologyhttps://www.linkedin.com/in/thegoodtomchihttps://www.vcsheet.com/who/tom-chihttps://www.instagram.com/thegoodtomchi/?hl=enAbout businessabc.nethttps://www.businessabc.net/About citiesabc.comhttps://www.citiesabc.com/​​​​​​​​​​​ About Dinis Guardahttps://www.dinisguarda.com/https://businessabc.net/wiki/dinis-guardaBusiness Inquiries- info@ztudium.comSupport the show

Nevena and John talk to Guy Morrow, Assoc Prof, Arts & Cultural Management, Uni of Meb, Is Spotify's AI ‘killing' Australian music? Guy Morrow is an Associate Professor of Arts and Cultural Management at the University of Melbourne, Australia. His research interests include artist‑centred approaches to cultural management and the impact of digitalisation, datafication and artificial intelligence on music artists within music ecosystems. His work combines academic rigour with arts sector collaboration to develop actionable insights for artists, managers and cultural organisations. He is also the current president of the International Music Business Research Association (IMBRA). Guy’s current contract research project is examining digital platform interactions to assess the performance of Australian artists on Spotify’s algorithmic playlists for the Victorian Music Development Office. One of his previous research contracts explored the shifting ground beneath music artist manager remuneration for the Association of Artist Managers in Australia while another developed an impact framework for the Science Gallery Network. Guy is also part of a project that has received AU$100,000 in proof-of-concept funding from Research, Innovation and Commercialisation at the University of Melbourne, ArtCert, which is developing an innovative response to shortcomings in current artwork authentication practices. The project aims to use blockchain and computational methods to validate the authenticity of painting collections. Guy also has a vast record of achievement in the creative and cultural industries and has worked with many of Australia’s best-known musicians within various popular music scenes through direct management, and also through music and design work. Guy was the founding co-manager of the band Boy & Bear and in this capacity received five Australian Recording Industry Association (ARIA) Awards, as well as Gold and Platinum Awards from ARIA. https://theconversation.com/is-spotifys-ai-killing-australian-music-what-we-found-from-analysing-more-than-2-million-tracks-276984 “The objective of streaming platforms is to maximise user engagement. Spotify does this by allowing users to discover new music in various ways, including through manual search and exploration, editorial (human-made) playlists, and AI-recommended playlists. Algorithms have been criticised for amplifying the influence of superstars – and the corporate interests that support them – while also potentially narrowing listeners' musical preferences. Spotify's AI does have a significant influence on the listening habits of its subscribers. But is this a problem?” The post Sat, 21st March, 2026: Guy Morrow, Assoc Prof, Arts & Cultural Management, Uni of Meb, Is Spotify's AI ‘killing' Australian Music? appeared first on Saturday Magazine.

In this episode of From the Helm, Grady sits down with EBR Systems (ASX:EBR) President and CEO John McCutcheon, to discuss their innovative, one-of-a-kind implant treatment for heart failure patients, the pathway to widespread adoption, and scaling plans for future growth.

In this episode of From the helm, Grady chats with 4D Medical (ASX:4DX) Founder and CEO Andreas Fouras to reflect on the meteoric rise of their lung imaging technology and detail their future plans for further global expansion.  

In this episode of From the Helm, Grady sits down with Mesoblast Director Silviu Itescu, to unpack the recent approval and launch of their Ryoncil drug for children, their outlook for the next 12 months in capturing the adult market, and their extensive pipeline of further products.

In this episode of From the Helm, Grady is joined by Clarity Pharmaceuticals (ASX:CU6) Executive Chairperson Alan Taylor & Bell Potter Senior Analyst John Hester, for a deep dive into their next-generation radiopharmaceutical technology for both early-stage cancer diagnosis and treatment.  

In this episode of From the Helm, Grady chats with Saluda Medical (ASX:SM1) President and CEO Barry Regan to discuss their recent developments since their IPO in November, their developmental drug for the treatment of chronic pain, and what is on the horizon looking ahead. 

In this compelling interview, Belinda shares her journey uncovering the influence of industry and religious organisations on dietary guidelines, the truth behind the Blue Zones, and the fight for honest health information. Discover how industry, history, and personal resilience shape our understanding of longevity and health.Chapters00:00 Introduction and Background of Belinda's Journey01:15 Gary's Medical Journey and the Impact of Diet10:25 The Personal Transformation Through Adversity19:49 Exploring the Blue Zones and Their Misconceptions34:37 The Role of Olive Oil and Animal Fats in Diets40:21 Exploring the Dietary Practices of Blue Zones46:05 Commercialisation and Influence of the Blue Zones48:10 Historical Influences on Dietary Guidelines57:45 Personal Resilience in the Face of Criticism

Zak Mir talks to Paul Emmitt, CEO of Powerhouse Energy, about recent progress at the company, including its pioneering integrated technology that converts non-recyclable waste into low-carbon energy, and its revenue-generating engineering consulting division. They discuss PHE's proven technology, its projects and newsflow drivers.Powerhouse Energy: Turning Non‑Recyclable Waste into Low‑Carbon EnergyPowerhouse Energy is positioning itself where two urgent problems intersect: mounting non‑recyclable waste and the need to decarbonise industrial energy. The company has developed an integrated waste‑to‑energy solution that converts difficult waste streams into useful products — syngas, hydrogen or power — using a robust, proven process based on a rotating kiln.What Powerhouse Energy offersAt its core, Powerhouse Energy provides a technology platform and engineering capability that turns problematic waste into real value. Rather than competing with recycling, it tackles the residual fraction that typically goes to landfill or is incinerated.Key outcomes the company targets: Production of syngas that can be used for power or as a chemical feedstock Hydrogen production from syngas On‑site power to reduce reliance on grid electricity or volatile natural gas Support for corporate decarbonisation and waste management strategies How the technology works — simple and provenPowerhouse Energy's process is a gasification system built around a rotating kiln. That configuration brings two advantages: Robustness — rotating kilns are a proven industrial technology with predictable behaviour and maintenance profiles. Flexibility — the system handles a wide range of non‑recyclable feedstocks and produces a controllable syngas stream for different downstream uses. The downstream equipment—gas cleanup, conditioning and conversion units—uses established industrial technology, which lowers technical risk for potential customers and investors.The Feedstock Testing Unit: the turning pointOne of the most important recent milestones was the completion of a feedstock testing unit (FTU) at the company's Brandon site in March last year. The FTU serves several crucial purposes: It lets potential clients bring their waste and see how it performs through the process. It provides a platform for ongoing R&D and for tuning the process to specific feedstocks. It acts as a commercial proof point that the technology works at scale prior to a full build‑out. As the CEO put it succinctly:"The technology is here for people to see and see work." Commercialisation pathway and project landscapePowerhouse Energy is working across several geographies and project types, from licensing and royalties to design‑build‑operate models where it retains control of delivery.Current project highlights and opportunities include: An Australia project operating under a licensing and royalty arrangement, where the client controls the timeline and delivery. A proposed design, build and operate facility at Balamina (planning application submitted), which would allow the company to drive the project and capture engineering revenues. Active discussions in the Middle East, Europe and the Caribbean for a mix of larger and smaller commercial units. Importantly, many enquiries are becoming tangible opportunities: in the past 12 months the company received roughly 50–60 enquiries and has around a dozen genuine opportunities under discussion. That pipeline is a positive signal of market interest.Why market valuation lags — and what will change itPowerhouse Energy's market capitalisation sits around £15 million, while the global waste‑to‑energy market runs into the billions. That gap reflects the typical early‑stage dynamic: technology proven at demonstration scale must cross the commercial threshold before valuations re‑rate.The decisive inflection point will be a signed contract for the first commercial unit. That could be: The Australia project concluding financial due diligence and executing the contract A smaller commercial unit (2.5–10 tonnes per day) sold to a customer to prove on‑site commercial operation Obtaining a first commercial order validates technology, starts revenue recognition and reduces perceived risk for future customers and investors. The company is open to creative commercial structures to overcome the "nobody wants to be first" problem, including moving or deploying the FTU to a partner site as a demonstration of commerciality.What to watch nextFor anyone tracking the company, the next major newsflow drivers are clear: Execution of the first commercial contract — Australia or a smaller pilot commercial unit. Planning approval and progression of the Balamina design‑build‑operate project. Closing one of the mid‑sized international opportunities in Europe, the Middle East or the Caribbean. Deployment options for the FTU to accelerate commercial proofs and client acceptance. Where Powerhouse Energy sits in the energy transitionThere is sometimes a binary narrative that only electrification and “100% renewable” solutions are green. In practice, the waste problem persists and requires pragmatic, low‑carbon solutions. Powerhouse Energy is not positioned as a replacement for recycling but as a complementary pathway: it deals with materials that would otherwise be landfilled or poorly controlled incinerated.By turning that residual waste into syngas or hydrogen, the company helps organisations meet waste management targets, reduce fossil fuel dependence for site power and advance decarbonisation strategies in industries where waste remains an intractable problem.SummaryPowerhouse Energy has moved from concept to demonstrable technology. With a functioning feedstock testing unit, a growing pipeline of enquiries and concrete projects under discussion, the company's next milestone is commercial traction — a signed first unit. When that happens, it will mark the transition from technology validation to revenue generation and should materially change market perception.For organisations wrestling with non‑recyclable waste and industrial decarbonisation, Powerhouse Energy offers a pragmatic, proven route to convert waste into useful, low‑carbon energy streams.

durée : 00:02:26 - Bientôt chez vous - Pour la première fois dans le monde, le gouvernement japonais a approuvé la production et la commercialisation de traitements à base de cellules iPS. Des traitements aux résultats encourageants qui permettent notamment de lutter contre la maladie de Parkinson et les insuffisances cardiaques. Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

CapeTalk’s Sara-Jayne Makwala King is joined on Weekend Breakfast by Nontsikelelo Mpulo, (South African National Biodiversity Institute ) SANBI’s Director of Marketing, Communications and Commercialisation. Weekend Breakfast with Sara-Jayne Makwala King is the weekend breakfast show on CapeTalk. This 3-hour morning programme is the perfect (and perky!) way to kickstart your weekend. Author and journalist Sara-Jayne Makwala-King spends 3 hours interviewing a variety of guests about all things cultural and entertaining. The team keeps an eye on weekend news stories, but the focus remains on relaxation and restoration. Favourites include the weekly wellness check-in on Saturdays at 7:35am and heartfelt chats during the Sunday 9am profile interview. Listen live on Primedia+ Saturdays and Sundays between 07:00 and 10:00am (SA Time) to Weekend Breakfast with Sara-Jayne Makwala-King broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/AgPbZi9 or find all the catch-up podcasts here https://buff.ly/j1EhEkZ Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Lester Kiewit speaks to Sores Florus, Chairperson of the Southern African Aboriginal Congress who details a legal challenge by the Southern African Aboriginal Congress raising questions about land, indigenous recognition, and access to justice in South Africa. They also discussed the City of Cape Town’s plans to auction the Good Hope Centre, highlighting tensions between historical restitution and market-driven urban development. Good Morning Cape Town with Lester Kiewit is a podcast of the CapeTalk breakfast show. This programme is your authentic Cape Town wake-up call. Good Morning Cape Town with Lester Kiewit is informative, enlightening and accessible. The team’s ability to spot & share relevant and unusual stories make the programme inclusive and thought-provoking. Don’t miss the popular World View feature at 7:45am daily. Listen out for #LesterInYourLounge which is an outside broadcast – from the home of a listener in a different part of Cape Town - on the first Wednesday of every month. This show introduces you to interesting Capetonians as well as their favourite communities, habits, local personalities and neighbourhood news. Thank you for listening to a podcast from Good Morning Cape Town with Lester Kiewit. Listen live on Primedia+ weekdays between 06:00 and 09:00 (SA Time) to Good Morning CapeTalk with Lester Kiewit broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/xGkqLbT or find all the catch-up podcasts here https://buff.ly/f9Eeb7i Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567See omnystudio.com/listener for privacy information.

Send us a text and let us know what you think of our podcast![Transcript of text messages between Paul and Geoff #2862768/2026. Subject: podcast content suggestions]PAUL: What shall we talk about in this podcast, Geoff? We've literally nothing to go on right now. No new Doctor Who for ages.GEOFF: CBAPAUL: Ooh! Cybermen, Banshees and Autons?GEOFF: NoPAUL: [search request: 'CBA'. Search returns results on 'CBA - acronym, vernacular usage] Oh... um... right.. er... anyway-GEOFF: Tennant's coming back. That's the rumour.PAUL: What? Seriously? OK... er... let's start with that then, and see what occurs!That's what happened. Honestly. We started talking about the rumours regarding the return of you-know-who to the show and then at around 7 minutes, Geoff cheered up and all kinds of topics flew across our virtual studio.Put your seatbelts on, listeners! You don't want to miss this ride!Chapters00:00 Introduction, Winging it and Overview of Rumours02:27 Diving into Doctor Who Rumours05:19 The Nature of Leaks and Marketing07:45 First mention of Avatar10:52 Speculations on Future Showrunners13:32 Marvel and Doctor Who: A Shared Nostalgia?16:27 The State of Cinema and Originality19:41 The Changing Landscape of Cinema24:39 Nostalgia and its Impact on Storytelling30:32 The Commercialisation of Creativity37:19 Doctor Who: A Reflection on Change and Continuity38:21 Nostalgia vs Innovation in Fandom41:11 Anticipation for Upcoming Doctor Who Content43:30 Exploring New Audio Adventures and Comics44:47 Audience and Community Feedback49:27 Future PlansSupport the show Subscribe to Who Corner to Corner on your podcast app to make sure you don't miss an episode! Now available to watch on YouTube! Join the Doctor Who chat with us and other fans on Twitter and Facebook! Visit the Who Corner to Corner website and see our back catalogue of episodes! Visit the WHOC2C merch store! Enjoying what we do? Consider joining our Explorers Subscription plan for more content! Who Corner to Corner: Great guests and 100% positive Doctor Who chat!

In this episode of Resilience Unravelled, Russell shares heartfelt Christmas and holiday greetings while reflecting on the diverse experiences people may have during the festive season. The discussion highlights the joy, reflection, and rejuvenation often associated with Christmas, as well as the challenges and pressures some might face, especially amidst family dynamics and commercial expectations. Emphasis is placed on the importance of choice and self-compassion, offering alternative ways to celebrate and cope with the season. The episode concludes with a toast to resilience and best wishes for the coming year.00:00 Welcome and Holiday Greetings00:23 The Joy and Reflection of Christmas01:18 Challenges and Resilience During the Holidays03:07 Commercialisation and Alternative Celebrations04:30 Finding Personal Joy and Resilience07:02 Grief and Gratitude at Christmas08:16 Final Thoughts You can contact us at info@qedod.comResources can be found online or link to our website https://resilienceunravelled.com

In this episode, COP's Michele Schiavone breaks down why Italy is primed for floating offshore wind and what it will take for the country to turn a vast early stage pipeline into real projects. The conversation explores the state of Italian offshore wind policy, the delay in national auctions, the progress of landmark projects such as Seven Seas Med, and the wider potential of floating wind across the Mediterranean. We look at the routes to market that investors need, the supply chain capabilities already in place, and the realistic outlook for construction by the end of the decade. It is a clear and grounded look at a market that could shape the next era of European offshore wind.This episode is hosted, produced and edited by Leonard Müller.Reach out to us at: podcasts@inspiratia.comFind all of our latest news and analysis by subscribing to inspiratia Interested in tickets for one of our events? Email conferences@inspiratia.com or buy them directly on our website.Listen to all our episodes on Apple Podcasts, Spotify, and other providers. Music credit: NDA/Show You instrumental/Tribe of Noise©2025 inspiratia. All rights reserved.This content is protected by copyright. Please respect the author's rights and do not copy or reproduce it without permission.

What if a molecule could help you live longer, sleep better, and feel more energised—without the hype?In this episode of the Health Up podcast, Anthony Hartcher chats with scientist and entrepreneur Chris Burres, co-founder of MyVitalC, about the groundbreaking molecule ESS60. Discovered in 1985 and backed by Nobel Prize-winning research, ESS60 has shown remarkable potential in longevity, energy, sleep quality, and cellular health.Chris shares:The surprising origin story behind his journey into health science (hint: it involves a Lamborghini)How ESS60 works inside the mitochondria to reduce oxidative stressReal-life testimonials, including recovery stories from pets and elite athletesThe science behind better sleep, improved focus, and enhanced recoveryHis top biohacks for living longer and better

Join Professor Michelle Barbour in this captivating conversation with Professor Marc Holderied from the University of Bristol's School of Biological Sciences. Discover how a serendipitous encounter with a fluffy moth in Costa Rica sparked a 30-year scientific journey that led to the development of ultra-thin, nature-inspired sound-absorbing materials.  

Aujourd'hui, Laura Warton Martinez, sophrologue, Bruno Poncet, cheminot, et Charles Consigny, avocat, débattent de l'actualité autour d'Alain Marschall et Olivier Truchot.

In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Anthony Cilento, vice president, data science & customer insights, at Bayer, in a post-Axtria Ignite 2025 discussion on the conference and agentic AI more generally. Cilento speaks to the advancement from GenAI to agentic AI, what's changed for his own team in this regard and what's required by way of a culture shift more generally, as well as speaking to the changes necessary in the advanced therapies space when it comes to commercialisation. You can listen to episode 206a of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Stacey Norman and J Sbu hosted a discussion with listeners about the impact of over-commercialising residential areas. The conversation was prompted by recent changes in places like Umhlanga, where new business developments, including a proposed casino, have sparked debate among residents. Listeners described the transformation of quiet, seaside towns into busy commercial centres, raising concerns about increased traffic, noise, and pressure on local infrastructure. Stacey shared her own experiences of water, sewage, and traffic issues, noting that the area's infrastructure now struggles to cope with the growing number of businesses and visitors.

Our guest this week is Vicky Alexandrou, co-founder of Woven Optics.Over the past eight years, Vicky has helped design and build a handheld microscope that lets you measure wool fibre diameter right there in the yards or shed. Instead of waiting for lab results, you clip a small sample, take a few quick images along the staple, and within seconds, the device tells you the mean micron, standard deviation, coefficient of variation, and comfort factor.You can scan the sheep's ear tag so the data is linked instantly, meaning decisions on classing, culling or breeding can be made on the spot with the most up-to-date information.Vicky and Ferg also chat about the importance of industry collaboration, the current commercialisation of Woven Optics, and the future potential of AI in agriculture.Woven Optics is available now through your local Heiniger representative. Head Shepherd is brought to you by neXtgen Agri International Limited. We help livestock farmers get the most out of the genetics they farm with. Get in touch with us if you would like to hear more about how we can help you do what you do best: info@nextgenagri.com.Thanks to our sponsors at MSD Animal Health and Allflex, and Heiniger Australia and New Zealand. Please consider them when making product choices, as they are instrumental in enabling us to bring you this podcast each week.Check out Heiniger's product range HERECheck out the MSD range HERECheck out Allflex products HERE

The Walton Institute at South East Technological University (SETU) is inviting businesses to participate in an exciting, free webinar, 'Unlock Innovation with SETU,' on Wednesday, 10 September 2025, at 12:00 p.m. This one-hour online event is designed to showcase how companies, particularly small and medium-sized enterprises (SMEs), can partner with SETU's world-class research and development centres to drive growth, boost competitiveness, and accelerate innovation. SETU is home to four of Enterprise Ireland's Technology Gateways, each offering specialised expertise and state-of-the-art facilities: SEAM (Advanced Manufacturing), PMBRC (Pharmaceutical & Molecular Biology), Design+ (Product Design), and the ICS Technology Gateway at Walton Institute (Digital and Communications Technologies). During the webinar, speakers will share insights into emerging trends, breakthrough innovations, and real-world applications relevant to industries across the region. The webinar will begin with a welcome from Dr James O'Sullivan, Head of Commercialisation at SETU, who will provide an overview of SETU's industry engagement model. He will be followed by short presentations from experts, including Dr Ramesh Raghavendra on advanced manufacturing, Liam Fitzgerald on digital transformation, Ailish Delaney on product and industrial design, and Dr Niall O'Reilly on the latest developments in pharmaceuticals and biotechnology. The session will conclude with a live panel discussion and audience Q&A, offering participants a valuable opportunity to connect directly with Gateways and explore how SETU can support their innovation goals. This webinar is particularly relevant to business owners, technical managers, start-ups, scale-ups, and innovation teams interested in collaborating with academic research centres to develop new products, processes, or services. Whether you're starting out or scaling up, the event will provide clear, practical guidance on accessing funding, research support, and advanced infrastructure through SETU's Technology Gateways. Organised by the Walton Institute in partnership with Waterford Chamber of Commerce and Toys4Engineers, this event reflects SETU's continued commitment to driving regional innovation and supporting enterprise through collaboration. Webinar Details Title: Unlock Innovation with SETU, Connecting regional business with world-class expertise Date: Wednesday, 10 September 2025 Time: 12:00 PM - 1:00 PM Location: Online (Zoom) Cost: Free Registration: Register now on Eventbrite For more information on SETU's Technology Gateways and how your business can get involved, visit www.waltoninstitute.ie or contact the team directly at info@waltoninstitute.ie. Don't miss this chance to explore how collaborative innovation with SETU can unlock your business's potential. The four Technology Gateways are part of the Enterprise Ireland Technology Gateway Network, co-funded by the Government of Ireland and the European Union through the ERDF Southern, Eastern & Midland Regional Programme 2021-27. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, LinkedIn, Facebook, Instagram, TikTok and Snapchat.

Pour sa troisième saison, Arnaud Demanche vient tous les matins à 8h20 pour poser son oeil sur l'actualité du jour. Cinq minutes de rire, pour se réveiller avec le sourire !

Comments, guest ideas: theasiaclimatecapitalpodcast@gmail.comJoseph Jacobelli and Toby Chan unpack the dynamic landscape of climate tech investing in Asia. The discussion highlights current VC trends, financing gaps, and the transition from emerging tech to mainstream infrastructure, with case studies from maritime and aviation. Discover why Asia is gaining ground amid US policy shifts and how policy, capital, and supply chains are driving change in the region.ABOUT TOBY: Toby is a co-founder of Audacy Ventures Limited, focused on catalysing and scaling decarbonisation technologies critical to the energy transition post his prior career in traditional energy and renewables. Audacy is an early growth stage investor and supports technologies related to energy efficiency, transportation and industrial decarbonisation, that are in early stages of commercialisation particularly in the APAC region.Toby has 20 years of investments and advisory experience across energy, infrastructure, technology, real estate and natural resources. Toby advised on over US$15bn of transactions whilst at Macquarie Capital and was part of the founding team of Kerogen Capital, a specialist in international energy investments with over US$2 billion AUM.FEEDBACK: Email Host | HOST, PRODUCTION, ARTWORK: Joseph Jacobelli | MUSIC: Ep0-29 The Open Goldberg Variations, Kimiko Ishizaka Ep30-50 Orchestra Gli Armonici – Tomaso Albinoni, Op.07, Concerto 04 per archi in Sol - III. Allegro. | Ep51 – Brandenburg Concerto No. 4 in G, Movement I (Allegro), BWV 1049 Kevin MacLeod. Licensed under Creative Commons: By Attribution 4.0 License

In this episode of the Decarb Connect Podcast, Alexandra Cameron is joined by Garrett Boudinot, climate scientist and CEO of VyCarb, a Brooklyn-based startup pioneering a novel approach to carbon dioxide removal (CDR). VyCarb's technology harnesses the natural carbon cycle of water to convert CO₂ into stable bicarbonate, offering a verifiable and permanent storage pathway that bypasses the geographic and infrastructure limitations of conventional geologic storage.Garrett shares how his background in ocean carbon chemistry led to the development of a modular, sensor-integrated system that operates at low CO₂ concentrations and near industrial emitters. The conversation explores how VyCarb's solution is being piloted with major industrial players like Rio Tinto and BlueScope Steel, and how the technology could support both voluntary carbon markets and direct decarbonization across sectors.What You'll Learn in This Episode:·       How VyCarb mimics ocean chemistry to convert CO₂ into stably stored bicarbonate·       Why low-purity CO₂ streams—common across industry—are a key focus for deployment·       The limitations of geologic CO₂ storage and how VyCarb overcomes them·       How integrated sensing enables real-time verification and control of the carbon conversion process·       Practical implications for cement, steel, aluminum, and oil & gas emitters·       How existing wastewater discharge permitting can support project rollout·       Insights into VyCarb's current pilot in Brooklyn and its industrial integration roadmap·       What scale-up looks like and why the economics could reach below $100/tonShow links: -          Connect with Garrett Boudinot and the team at VyCarb-          Follow Alex Cameron on LinkedIn and find how to get involved with the membership and work of Decarb Connect-          Join Alex and a network of hardtech investors and series B+ tech disruptors at Decarb TechInvest in Boston (September 2025) Want to learn more about Decarb Connect? We provide insights and introductions that derisk decision-making and support industrial leaders in deploying decarbonization and low carbon product strategy. Our global membership platform, events and facilitated introductions support commercial decarb planning and business models around the world. Our clients include the most energy-intensive industrials from cement, metals and mining, glass, ceramics, chemicals, O&G and many more along with technology disruptors, investors and advisors.  If you enjoyed this conversation, find out about our portfolio of events in US, Canada, UK and Europe – or explore our Decarbonisation Leaders Network (DLN), and learn why more than 200 members from the energy-intensive sectors have joined to share insights, meet partners who can accelerate their net zero plans and why it's the fastest growing network of its kind.        (01:31) - – Welcome and introduction to Garrett (00:00) - Chapter 2 (02:41) - – The Origin of Vycarb (00:00) - Chapter 4 (05:54) - – How the Technology Works (00:00) - Chapter 6 (09:11) - - Where Vycarb is at in its funding journey (00:00) - Chapter 8 (12:41) - - Why Industrial Giants Are Backing Vycarb (00:00) - Chapter 10 (22:10) - - How the Vycarb System Works (00:00) - Chapter 12 (27:58) - – Turning Industrial Wastewater Into a Carbon Removal Opportunity (00:00) - Chapter 14 (29:52) - – Vycarb's Pilot Facility in Brooklyn (00:00) - Chapter 16 (33:17) - – Addressing Safety & Environmental Concerns (00:00) - Chapter 18 (36:57) - - Funding, Partnerships & Scaling (00:00) - Chapter 20 (39:20) - – Looking Ahead: The Path to Commercialisation (00:00) - Chapter 22 (40:31) - – Final Thoughts & Reflections

South East Technological University (SETU) has been awarded funding as part of a prestigious European consortium delivering the BECEE project - Balanced and Enhanced Collaboration for an Entrepreneurship Ecosystem - a transformative initiative aimed at fostering entrepreneurial talent and strengthening innovation capacity across Europe. Led by Rachel O'Dowd, Prof. Helen Hughes, and Dr Ultan McCarthy from SETU's Department of Land Sciences, with Dr James O'Sullivan, Head of Innovation and Commercialisation at SETU, the project is delivered in close collaboration with Professor Bill O'Gorman of Dungarvan Enterprise Centre. BECEE is supported by the European Institute of Innovation and Technology (EIT), with cross-funding and endorsement from EIT Digital, EIT Climate, EIT Food, and EIT Health. The €1.34 million project brings together four forward-looking higher education institutions - Hanze University of Applied Sciences (Netherlands), Zurich University of Applied Sciences (Switzerland), South East Technological University (Ireland), and Universiteti "Aleksandër Moisiu" Durrës (Albania) - working in tandem with four innovation-driven enterprises: KPN (Eindhoven, Netherlands), Innofuse (Zurich, Switzerland), Dungarvan Enterprise Centre (Ireland), and Linda Laboratory (Durrës, Albania). Speaking about SETU's role, Professor Helen Hughes said, "We are hugely excited by the opportunity to be part of this excellent European consortium furthering innovative solutions, strengthening and supporting our entrepreneurial talent in the region in conjunction with our industrial partner Dungarvan Enterprise Centre. It further strengthens the focus and expertise available within the Department of Land Sciences for entrepreneurship that has been developing across the last decade." The BECEE project will have a tangible impact on regional and national entrepreneurship by developing practical, scalable models to support innovators, start-ups and SMEs. Activities will include training, mentorship, policy development, and new pathways for academic-industry engagement - all contributing to SETU's strategic ambition of connecting for impact. Dr James O'Sullivan noted, "This initiative reflects SETU's deepening commitment to delivering innovation and knowledge exchange across our region, working hand in hand with our enterprise partners to create a more resilient, sustainable, and inclusive entrepreneurial ecosystem." The project is already underway and will roll out activities over the next two years across the partner regions. It aligns strongly with SETU's focus on collaboration, regional development, and addressing key societal challenges through innovation. More information is available at: https://eit-hei.eu/projects/becee/

Émission du 15/05/2025 Aujourd'hui, nous avons le plaisir de recevoir deux projets étudiants portés par des étudiants en BUT Techniques de Commercialisation. Plein phare sur Étoiles en scène, un concours de jeunes talents qui met en avant des étudiants artistes : musiciens, danseurs, performeurs, créateurs, cheerleaders. Le concours se déroulera le samedi 24 mai 2025 […] L'article Sortez! – Étoiles en scène / Au Cœur des Maux est apparu en premier sur Radio Campus Tours - 99.5 FM.

University College Dublin (UCD) and Teagasc have today announced that applications are now open for the second Food and Agriculture Sustainable Technology Innovation Programme (FAST-IP) which begins this September. FAST-IP, a specialist agrifood technology innovation programme, provides participants with the skills necessary to evaluate, select and validate ideas for new products and services in the agrifood sector and to accelerate the commercialisation pathway of these ideas. Aligned with Ireland's national agrifood strategy, Food Vision 2030, FAST-IP also aims to support establishing Ireland as a leader in sustainable food systems by balancing climate-smart agriculture, environmental and economic sustainability, and innovation. Participants on the inaugural programme, which ends in August, are currently developing business plans for new market ready innovations in areas ranging from soil health, food allergens, pest control and bioeconomy. Twelve (12) places are available on the full-time, 12-month, in-person programme aimed at mid-career professionals, which is delivered by the UCD School of Biosystems and Food Engineering in partnership with Teagasc at the AgTechUCD Innovation Centre at UCD Lyons Farm in Co. Kildare. FAST-IP provides participants with a €38,000 tax-free scholarship during the programme. Edel Mitchell, Programme Manager, FAST-IP, said, "We are delighted to open applications for our second FAST-IP programme. This is a wonderful opportunity for mid-career professionals to embrace their entrepreneurial ambitions and develop market led solutions to real problems experienced by the global agrifood sector. The practical needs led innovation process enables participants to deep dive and forensically understand pressing challenges for the agrifood sector and build innovative solutions. If you are interested in embarking on this journey and leveraging the unparallelled access to industry experts, mentorship and cross sectoral immersive opportunities I would encourage you to apply for the FAST-IP programme." FAST-IP uses design-thinking methodologies and has a practical focus. Through the programme participants, working in teams, learn how to conduct needs-led innovation to develop market validated solutions to unmet needs in the areas of agricultural technology and food sustainability sectors. Participants also spend 8-10 weeks immersed in agricultural environments including farms, food processing companies, and Teagasc locations throughout the 12-month programme. Dr Siobhán Jordan, Head of Technology Transfer and Commercialisation, Teagasc, said, "FAST-IP aims to position Ireland as a global innovator in AgTech and food systems by fostering the creation of high-potential start-ups, scalable businesses and sustainable solutions that address challenges in areas including, climate change, food security, productivity and economic diversification. We are now seeking applications from mid-career individuals who are interested in embarking on this cutting-edge, immersive programme to create innovative, sustainable agri-food solutions with expert mentorship and entrepreneurial training by UCD and Teagasc." FAST-IP is accredited by UCD at Level 9 on the National Qualifications Framework and participants who complete the programme will be awarded a Graduate Diploma in Agrifood, Innovation and Entrepreneurship. Professor Nick Holden, Professor of Biosystems Engineering in the UCD School of Biosystems and Food Engineering is the Academic Director of the Graduate Diploma Programme. The FAST-IP programme, running until the end of 2029, forms part of Enterprise Ireland's Innovators' Initiative which is co-funded by the European Regional Development Fund (ERDF) and the Department of Enterprise, Trade and Employment. UCD and Teagasc have strong reputations for academic and research excellence in the areas of Sustainable Food Systems, Agriculture, and Food Science, and are utilising their extensive networks, connections, domain ...

Discussion sur la commercialisation des robots humanoïdes Unitree en Chine, désormais accessibles au grand public. Jérôme Colombain et Bruno Guglielminetti s'interrogent sur l'évolution rapide de ces technologies, notamment leur intégration de l'intelligence artificielle et leur mobilité avancée. La conversation explore aussi les enjeux liés à l'acceptation sociale de ces robots, leur possible utilisation dans le domaine militaire et la place qu'ils pourraient prendre dans notre quotidien.

Let us know your thoughts. Send us a Text Message. Follow me to see #HeadsTalk Podcast Audiograms every Monday on LinkedInEpisode Title: